loading... download flash
spacer spacer spacer spacer spacer
 
 
Annual Cash Flow Download to Excel Download to Excel

Time Frame 

As of12/0712/0612/0512/0412/03
Net Income (Loss)-181.01-274.32-228.00-155.08-110.95
Depreciation/Amortization9.447.1110.7514.3414.20
Net Incr (Decr) in Assets/Liab.-25.33-30.3710.7913.13-6.46
Cash Flow from Disc. Operationsn/an/an/an/an/a
Other Adjustments-Net34.6926.839.843.493.77

Net Cash Flow from Operating-162.22-270.75-196.61-124.12-99.44

(Acq.)Disp. of Subs. Businessn/an/an/a-1.00n/a
Incr (Decr) in Securities Invest.166.51190.09-58.9117.43-31.03
Other Cash Flow from Investingn/a-4.00n/a0.50-0.84

Net Cash Flow from Investing163.71176.24-67.8713.32-36.44

Issue (Purchase) of Equity5.80138.35202.3387.4436.62
Issue (Repayment) of Debtn/an/a65.0828.2796.34
Incr (Decr) in Borrowingn/an/an/an/an/a
Dividends, Other Distributionn/an/an/an/an/a
Other Cash Inflow (Outflow)6.6710.11n/an/an/a

Net Cash Flow from Financing12.47148.47267.41115.72132.95

Effect of Exchange Rate on Cashn/an/an/an/an/a
Cash or Equivalents at Year Start77.6423.6920.7615.84n/a
Cash or Equivalents at Year End91.6077.6423.6920.76n/a

Net Change in Cash or Equiv13.9653.952.934.92-2.93


in millions of USD
Printer Friendly Page
spacer
spacer
spacer spacer
Back to Top
footer header
Home | About CVT | Media | Investors | Careers | Terms of Use | Privacy Policy | Contact Us | Site Map | webmaster@cvt.com
© 1999-2008, CV Therapeutics, Inc. All rights reserved.
 
spacer
Please Note: The websites of CV Therapeutics, Inc. are not intended to provide medical advice,
nor is any information here a substitute for professional healthcare. Consult your doctor or other
healthcare provider for information about your diagnosis, treatment, or condition.